BCY17901 is a potent irreversible transferrin receptor 1 (TfR1) inhibitor (Ki=12 nM). BCY17901 inhibits TfR1-mediated endocytosis and iron transport, and suppresses the proliferation of tumor cells dependent on iron metabolism. BCY17901 can be used in the research of solid tumors (such as breast cancer, glioblastoma) and neurodegenerative diseases[1].
Molecular Weight:
2236.46
CAS Number:
[2772542-34-2]
Formula:
C99H134N24O30S3
Target:
Transferrin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
